Table 3.

Decompensation events and specific mortality.

Parameter	Subjects with SARS-CoV-2 Infection n = 45	Subjects without SARS-CoV-2 Infection n = 100	p-Value
No ACLF	51.1% (23)	70% (70)	0.0446
ACLF ACLF 1 ACLF 2 ACLF 3	48.9% (22) 63.6% (14) 27.3% (6) 9.1% (2)	30% (30) 76.7% (23) 23.3% (7) 0%	0.0446 0.4070 0.3509 0.1804
CLIF C-OF, median values	7 [1–12]	5 [5–10]	<0.0001
CLIF C-ACLF, median values	47.22 [29.6–60.61]	43.09 [27.7–53.51]	0.0667
CLIF C-AD, median values	54.97 [37.63–71.69]	52.83 [37.02–80.2]	0.6122
Associated infection (%)	60% (27)	33% (33)	0.0041
Overall mortality (%)	46.7% (21)	15% (15)	0.0001
Mortality in subjects without ACLF	39.1% (9/23)	12.9% (9/70)	0.0141
Mortality in subjects with ACLF	54.5% (12/22)	20% (6/30)	0.0221

ACLF—acute-on-chronic liver failure, OF—organ failure, AD—acute decompensation.